Soloways Omega-3 Polyunsaturated Fatty Acids
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Soloways Omega-3 Polyunsaturated Fatty Acids, covering 2025-03-07 to 2025-03-07. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study of High-Dose Omega-3 (Soloways ™) Polyunsaturated Fatty Acids in Patients with Dyslipidemia Carrying FADS1/FADS2 Variants [NA]